Search

everythinglearnresearchcommunity

for

Search:↓

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

High testosterone increases heart disease risk in women with PCOS.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Menopausal hormone therapy is best for hot flashes, while other options include SSRIs, SNRIs, fezolinetant, and lifestyle changes.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.